Imodium Duo

Loperamide Hydrochloride and Dimeticone, the active ingredients in Imodium Duo, are an opioid receptor agonist and an antiflatulent presented as an oral over‑the‑counter product for use in adults and children. It relieves acute diarrhea, travel‑related diarrhea and reduces bloating and gas.

GNH USA supplies Imodium Duo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance.

Imodium Duo acts on intestinal motility and gas formation to treat several gastrointestinal conditions. - Acute diarrhea: reduces stool frequency and improves consistency by slowing intestinal transit. - Travelers' diarrhea: provides rapid symptom control for travelers experiencing sudden loose stools. - Bloating and gas: diminishes gas bubbles and abdominal distension, offering relief from discomfort.

Imodium Duo may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Constipation: reduced bowel movements leading to hard stools. - Abdominal cramps: mild to moderate stomach discomfort. - Nausea: feeling of sickness or urge to vomit. - Dry mouth: reduced salivation causing throat dryness. - Dizziness: light‑headed sensation, especially on standing. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Severe constipation or ileus: risk of bowel obstruction requiring medical attention. - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Cardiac arrhythmia: irregular heartbeat, reported rarely with high loperamide levels. - Toxic megacolon: extreme colon dilation, a medical emergency. - Central nervous system depression: drowsiness or reduced alertness in rare cases.

Before using Imodium Duo, consider the following precautions to ensure safe and effective therapy. - Assess dehydration: confirm adequate fluid and electrolyte replacement before initiating therapy. - Evaluate underlying infection: avoid use if diarrhea is caused by invasive bacterial pathogens such as C. difficile. - Limit duration: do not exceed 48 hours of continuous use without medical review. - Caution in hepatic impairment: dose may need adjustment in patients with liver dysfunction. - Avoid in children under two years: safety not established for this age group. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Imodium Duo can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide plasma levels and risk of toxicity. - Other antidiarrheal agents (e.g., bismuth subsalicylate): additive slowing of gut motility can cause severe constipation. - Opioid analgesics: combined central opioid effects may enhance sedation and respiratory depression.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs: may exacerbate constipation. - Sedatives or antihistamines: can increase dizziness or drowsiness. - CYP2C9 inhibitors (e.g., fluconazole): may modestly raise loperamide concentrations. - Rifampicin: may reduce loperamide effectiveness by inducing metabolism.